These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36433862)

  • 41. Technical Performance and Clinical Effectiveness of Drop Type With Adjustable Concentrator-Cell Free and Concentrated Ascites Reinfusion Therapy.
    Yamada Y; Harada M; Yamaguchi A; Kobayashi Y; Chino T; Minowa T; Kosuge T; Tsukada W; Hashimoto K; Kamijo Y
    Artif Organs; 2017 Dec; 41(12):1135-1144. PubMed ID: 28589706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
    Wang SZ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial.
    Narahara Y; Kanazawa H; Fukuda T; Matsushita Y; Harimoto H; Kidokoro H; Katakura T; Atsukawa M; Taki Y; Kimura Y; Nakatsuka K; Sakamoto C
    J Gastroenterol; 2011 Jan; 46(1):78-85. PubMed ID: 20632194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
    Ginès P; Titó L; Arroyo V; Planas R; Panés J; Viver J; Torres M; Humbert P; Rimola A; Llach J
    Gastroenterology; 1988 Jun; 94(6):1493-502. PubMed ID: 3360270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
    Chesta J; Brahm J; Latorre R; Gidi J; Hurtado C; Antezana C; Novoa X; Velasco M
    Rev Med Chil; 1990 Aug; 118(8):874-80. PubMed ID: 2152231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.
    Nagata Y; Kato K; Miyamoto T; Hirano H; Shoji H; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Matsushita H; Nagashima K; Saruta M; Boku N
    Support Care Cancer; 2020 Dec; 28(12):5861-5869. PubMed ID: 32253601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of cell-free and concentrated ascites reinfusion therapy (CART) in gynecologic cancer patients with a large volume of ascites.
    Wang L; Okubo T; Shinsaka M; Kobayashi A; Ogasawara M; Sakaguchi R; Nagai T; Seki H
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1614-20. PubMed ID: 26177394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis.
    Wong F; Gines P; Watson H; Horsmans Y; Angeli P; Gow P; Minini P; Bernardi M
    J Hepatol; 2010 Aug; 53(2):283-90. PubMed ID: 20541828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites. The role of postparacentesis plasma volume expansion.
    Forouzandeh B; Konicek F; Sheagren JN
    J Clin Gastroenterol; 1996 Apr; 22(3):207-10. PubMed ID: 8724259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.
    Altman C; Bernard B; Roulot D; Vitte RL; Ink O
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):5-10. PubMed ID: 9512946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites.
    Ronald J; Rao R; Choi SS; Kappus M; Martin JG; Sag AA; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY
    Cardiovasc Intervent Radiol; 2019 May; 42(5):720-728. PubMed ID: 30603968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RRI as Diagnostic and Follow up Indicator in Cirrhosis of the Liver with Hepatorenal Syndrome and Refractory Ascites.
    C AK; L P; Krishnamurthy A
    J Assoc Physicians India; 2019 Apr; 67(4):22-25. PubMed ID: 31299833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognosis of patients with ascites after PleurX insertion: an observational study.
    Riedel AN; Kimer N; Hobolth L; Gluud LL
    Scand J Gastroenterol; 2018 Mar; 53(3):340-344. PubMed ID: 29411667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.
    Planas R; Ginès P; Arroyo V; Llach J; Panés J; Vargas V; Salmerón JM; Ginès A; Toledo C; Rimola A
    Gastroenterology; 1990 Dec; 99(6):1736-44. PubMed ID: 1699835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical usefulness of concentrated ascites reinfusion therapy (CART) for gynecological cancer patients with refractory massive ascites due to cancerous peritonitis.
    Togami S; Hori S; Kamio M; Matsuo T; Yoshinaga M; Douchi T
    Eur J Gynaecol Oncol; 2014; 35(3):301-3. PubMed ID: 24984546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reinfusion of concentrated ascitic fluid versus total paracentesis. A randomized prospective trial.
    Graziotto A; Rossaro L; Inturri P; Salvagnini M
    Dig Dis Sci; 1997 Aug; 42(8):1708-14. PubMed ID: 9286238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low dose albumin for the prevention of renal impairment following large volume paracentesis in cirrhosis.
    Hussain W; Khalid AB; Usmani T; Ghufran A; Shah H
    Pak J Med Sci; 2015; 31(3):592-6. PubMed ID: 26150850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis.
    Chen H; Ishihara M; Horita N; Tanzawa S; Kazahari H; Ochiai R; Sakamoto T; Honda T; Ichikawa Y; Watanabe K; Seki N
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cell-Free Ascites Reinfusion Therapy(CART)Modified by Keisuke Matsusaki(KM-CART)at Our Hospital].
    Iwaki R; Shindo K; Kawahara H; Nanba N; Kuramoto Y; Beppu T; Uesugi T; Tanaka Y; Uesugi Y
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2165-2167. PubMed ID: 30692319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
    Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
    Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.